Catalent, Inc. 3 SEC Filings

Filed On	Filing
18 Jan 2024	Form 3: Hatzfeld Michael, Chief Accounting Officer No securities owned
02 Nov 2023	Form 3: McErlane David, Group President, Biologics Holds 19,552 shares of Common Stock
12 Sep 2023	Form 3: Barg Steven, Director No securities owned
30 Aug 2023	Form 3: Okey Stephanie, Director No securities owned
30 Aug 2023	Form 3: Ryan Michelle R, Director No securities owned
30 Aug 2023	Form 3: Damelio Frank A, Director No securities owned
30 Aug 2023	Form 3: Evoli Lisa, SVP, Chief HR Officer Holds 27,887 shares of Common Stock
07 Jul 2023	Form 3: Masanovich Matti, SVP, Chief Financial Officer Holds 0 shares of Common Stock
21 Feb 2023	Form 3: Ferraro Joseph Anthony, SVP, General Counsel, CCO Holds 0 shares of Common Stock
06 Feb 2023	Form 3: Zayas Ricardo, SVP, Operations, Biologics NA Holds 1,788 shares of Common Stock
21 Sep 2022	Form 3: Santiago Karen Murphy, VP & Chief Accounting Officer Holds 0 shares of Common Stock
19 Sep 2022	Form 3: Flynn Karen, Director Holds 12,952 shares of Common Stock
26 Aug 2022	Form 3: Riley Michael A., Pres. Bio Product Delivery Div Holds 6,592 shares of Common Stock
26 Aug 2022	Form 3: Lickfold Charles, SVP, CIO Holds 5,705 shares of Common Stock
26 Aug 2022	Form 3: Hunt Patricia, Pres. Consumer Health Div Holds 8,705 shares of Common Stock
26 Aug 2022	Form 3: Hawkeswood Thomas W, Pres. Pharma Prod Delivery Div Holds 5,712 shares of Common Stock
26 Aug 2022	Form 3: Boerman Manja, Pres. BioModalities Division Holds 13,260 shares of Common Stock
02 Nov 2021	Form 3: Gargiulo Mario, SVP Global Ops Large Molecule Holds 4,758 shares of Common Stock
02 Nov 2021	Form 3: Carletti Lorenzo, SVP Global Ops Small Molecule Holds 3,580 shares of Common Stock
02 Jun 2021	Form 3: Castellano Thomas P, SVP, Chief Financial Officer Holds 12,567 shares of Common Stock

Comments